
Medtronic Achieves Strongest Revenue Growth in a Decade with 124% Surge in U.S. Cardiac Ablation
Medtronic plcDescription
What this story covers
Medtronic reported its highest annual revenue growth in ten years, reaching $36.4 billion. Driven by breakthrough cardiac technologies and surgical robotics, the company balanced margin pressures with robust free cash flow and its 49th consecutive annual dividend increase.
Story snapshot
CompanyMedtronic plc
TickerMDT
VariantStandard detailed
Duration4:56
Filing type8-K
PeriodAnnual 2026
IndustryHealthcare & Pharmaceuticals
Accession0001628280-26-040034
Sources1
Full Story Script
Content not available for this story.